| scholarly article | Q13442814 |
| P50 | author | Bryan Williams | Q27840138 |
| Anthony J Sadler | Q62748460 | ||
| Justin Pollara | Q114519514 | ||
| David J Pickup | Q120587566 | ||
| P2093 | author name string | Caroline A Ray | |
| Ian T D Petty | |||
| Heather E Lynch | |||
| Katrina L Oie | |||
| P2860 | cites work | Hostile takeovers: viral appropriation of the NF-kB pathway | Q22241900 |
| Inhibition of IkappaB kinase by vaccinia virus virulence factor B14 | Q24312867 | ||
| Protein kinase PKR is required for platelet-derived growth factor signaling of c-fos gene expression via Erks and Stat3. | Q24535156 | ||
| The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase | Q24561643 | ||
| The E3L and K3L vaccinia virus gene products stimulate translation through inhibition of the double-stranded RNA-dependent protein kinase by different mechanisms | Q24642586 | ||
| Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action | Q24672548 | ||
| Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
| Detection of specific sequences among DNA fragments separated by gel electrophoresis | Q25939003 | ||
| Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei | Q27860728 | ||
| Toll-like receptors: from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity | Q28259757 | ||
| NF-kappaB and the immune response | Q28271031 | ||
| Good cop, bad cop: the different faces of NF-kappaB | Q28291669 | ||
| The dsRNA protein kinase PKR: virus and cell control | Q28298945 | ||
| The protein kinase PKR is required for p38 MAPK activation and the innate immune response to bacterial endotoxin | Q28344558 | ||
| NF-kappaB dictates the degradation pathway of IkappaBalpha | Q28588231 | ||
| Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase | Q29620280 | ||
| CrmE, a novel soluble tumor necrosis factor receptor encoded by poxviruses. | Q33834737 | ||
| Both carboxy- and amino-terminal domains of the vaccinia virus interferon resistance gene, E3L, are required for pathogenesis in a mouse model | Q33835582 | ||
| Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: role of IRF-1 and NF-kappaB | Q33886023 | ||
| Suppression of proinflammatory signal transduction and gene expression by the dual nucleic acid binding domains of the vaccinia virus E3L proteins | Q38309150 | ||
| Microarray analysis reveals characteristic changes of host cell gene expression in response to attenuated modified vaccinia virus Ankara infection of human HeLa cells. | Q38341228 | ||
| Identification of a ligand-induced transient refractory period in nuclear factor-kappaB signaling. | Q38923475 | ||
| The block in assembly of modified vaccinia virus Ankara in HeLa cells reveals new insights into vaccinia virus morphogenesis | Q39753058 | ||
| Gene expression and cytopathic effect of vaccinia virus inactivated by psoralen and long-wave UV light | Q39873004 | ||
| Differences in virus-induced cell morphology and in virus maturation between MVA and other strains (WR, Ankara, and NYCBH) of vaccinia virus in infected human cells | Q40008615 | ||
| Cloning and expression of foreign genes in vaccinia virus, using a host range selection system | Q40116789 | ||
| A cowpox virus gene required for multiplication in Chinese hamster ovary cells. | Q40127465 | ||
| Host response to the attenuated poxvirus vector NYVAC: upregulation of apoptotic genes and NF-kappaB-responsive genes in infected HeLa cells. | Q40362454 | ||
| Poxvirus protein N1L targets the I-kappaB kinase complex, inhibits signaling to NF-kappaB by the tumor necrosis factor superfamily of receptors, and inhibits NF-kappaB and IRF3 signaling by toll-like receptors | Q40542008 | ||
| Vaccinia virus induces apoptosis of infected macrophages | Q40695895 | ||
| The role of the PKR-inhibitory genes, E3L and K3L, in determining vaccinia virus host range | Q40712234 | ||
| Cowpox virus and other members of the orthopoxvirus genus interfere with the regulation of NF-kappaB activation | Q40781958 | ||
| Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line | Q41076591 | ||
| Complementation of a vaccinia virus host-range K1L gene deletion by the nonhomologous CP77 gene | Q41179712 | ||
| Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence | Q41684943 | ||
| Vaccinia virus host range genes | Q41716592 | ||
| Cowpox virus contains two copies of an early gene encoding a soluble secreted form of the type II TNF receptor | Q42601211 | ||
| IRF-1 induced cell growth inhibition and interferon induction requires the activity of the protein kinase PKR. | Q42825330 | ||
| Double-stranded RNA-binding protein E3 controls translation of viral intermediate RNA, marking an essential step in the life cycle of modified vaccinia virus Ankara | Q43894392 | ||
| The cowpox virus host range gene, CP77, affects phosphorylation of eIF2 alpha and vaccinia viral translation in apoptotic HeLa cells | Q45090422 | ||
| The N-terminal domain of the vaccinia virus E3L-protein is required for neurovirulence, but not induction of a protective immune response | Q45510140 | ||
| Cowpox virus genome encodes a second soluble homologue of cellular TNF receptors, distinct from CrmB, that binds TNF but not LT alpha | Q45768255 | ||
| Vaccinia virus-encoded elF-2α homolog abrogates the antiviral effect of interferon | Q45859752 | ||
| NF-kappaB suppression by the deubiquitinating enzyme Cezanne: a novel negative feedback loop in pro-inflammatory signaling | Q46820406 | ||
| Tumor necrosis factor receptor p75 mediates cell-specific activation of nuclear factor kappa B and induction of human cytomegalovirus enhancer | Q72287816 | ||
| Viruses and Toll-like receptors | Q81133043 | ||
| The vaccinia virus K3L gene product potentiates translation by inhibiting double-stranded-RNA-activated protein kinase and phosphorylation of the alpha subunit of eukaryotic initiation factor 2 | Q33930433 | ||
| Cowpox virus encodes a fifth member of the tumor necrosis factor receptor family: a soluble, secreted CD30 homologue | Q34032643 | ||
| Poxviruses and immune evasion | Q34172411 | ||
| Immunology 101 at poxvirus U: immune evasion genes | Q34209968 | ||
| The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses | Q34469355 | ||
| Circuitry of nuclear factor kappaB signaling | Q34514908 | ||
| Poxviral regulation of the host NF-kappaB response: the vaccinia virus M2L protein inhibits induction of NF-kappaB activation via an ERK2 pathway in virus-infected human embryonic kidney cells. | Q35024097 | ||
| Vaccinia virus infection attenuates innate immune responses and antigen presentation by epidermal dendritic cells | Q35101495 | ||
| Double-stranded RNA-dependent protein kinase activates transcription factor NF-kappa B by phosphorylating I kappa B. | Q35566028 | ||
| Construction and isolation of recombinant MVA. | Q35758629 | ||
| Double-stranded RNA is a trigger for apoptosis in vaccinia virus-infected cells. | Q35878092 | ||
| A third distinct tumor necrosis factor receptor of orthopoxviruses | Q36010238 | ||
| A20 inhibits NF-kappaB activation by dual ubiquitin-editing functions | Q36011021 | ||
| The role of Toll-like receptors in the host response to viruses | Q36097444 | ||
| Photochemical inactivation of viruses with psoralens: an overview | Q36261292 | ||
| The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defense | Q36370571 | ||
| Intermolecular duplexes formed from polyadenylylated vaccinia virus RNA. | Q36497272 | ||
| Toll-like receptors and RNA helicases: two parallel ways to trigger antiviral responses | Q36500879 | ||
| Mechanism of Synthesis of Vaccinia Virus Double-Stranded Ribonucleic Acid In Vivo and In Vitro | Q36577589 | ||
| Stable expression of the vaccinia virus K1L gene in rabbit cells complements the host range defect of a vaccinia virus mutant. | Q36621273 | ||
| IkappaB kinase complexes: gateways to NF-kappaB activation and transcription | Q36637874 | ||
| Transcriptional regulation via the NF-kappaB signaling module. | Q36637878 | ||
| Manipulation of the nuclear factor-kappaB pathway and the innate immune response by viruses | Q36637910 | ||
| Understanding orthopoxvirus interference with host immune responses to inform novel vaccine design | Q36728801 | ||
| RIG-I: tri-ing to discriminate between self and non-self RNA. | Q36738647 | ||
| Viral recognition by Toll-like receptors | Q36750780 | ||
| Nuclear factor-kappaB: activation and regulation during toll-like receptor signaling. | Q36755963 | ||
| Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines: scarification vaccination | Q36797094 | ||
| Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines: intra-nasal vaccination | Q36957606 | ||
| Induction of protein kinase PKR-dependent activation of interferon regulatory factor 3 by vaccinia virus occurs through adapter IPS-1 signaling | Q37000233 | ||
| The vaccinia virus K1L gene product inhibits host NF-kappaB activation by preventing IkappaBalpha degradation | Q37010771 | ||
| Nonreplicating vaccinia vector efficiently expresses recombinant genes | Q37299518 | ||
| A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling. | Q37421291 | ||
| Host range restriction of vaccinia virus in Chinese hamster ovary cells: relationship to shutoff of protein synthesis | Q37601006 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | NF-κB | Q411114 |
| Vaccinia virus | Q1986297 | ||
| P304 | page(s) | 177-186 | |
| P577 | publication date | 2009-09-01 | |
| P1433 | published in | Virology | Q7934867 |
| P1476 | title | Modified vaccinia virus Ankara can activate NF-kappaB transcription factors through a double-stranded RNA-activated protein kinase (PKR)-dependent pathway during the early phase of virus replication | |
| P478 | volume | 391 |
| Q38780546 | CCL2 expression is mediated by type I IFN receptor and recruits NK and T cells to the lung during MVA infection |
| Q35539329 | Cowpox virus induces interleukin-10 both in vitro and in vivo |
| Q36961137 | Cowpox virus inhibits human dendritic cell immune function by nonlethal, nonproductive infection. |
| Q37944321 | Innate immune recognition of poxviral vaccine vectors |
| Q38092466 | Modified Vaccinia virus Ankara: innate immune activation and induction of cellular signalling |
| Q35151746 | Modified vaccinia virus Ankara triggers type I IFN production in murine conventional dendritic cells via a cGAS/STING-mediated cytosolic DNA-sensing pathway |
| Q35962511 | Production of prostaglandin E₂ in response to infection with modified vaccinia Ankara virus |
| Q34262138 | Rapid expansion of CD8+ T cells in wild-type and type I interferon receptor-deficient mice correlates with protection after low-dose emergency immunization with modified vaccinia virus Ankara |
| Q34594898 | Recombinant modified vaccinia virus Ankara generating excess early double-stranded RNA transiently activates protein kinase R and triggers enhanced innate immune responses. |
| Q35800430 | Selection of recombinant MVA by rescue of the essential D4R gene |
| Q34780607 | Smallpox vaccines: targets of protective immunity |
| Q39323853 | The C11R gene, which encodes the vaccinia virus growth factor, is partially responsible for MVA-induced NF-κB and ERK2 activation. |
| Q36675284 | The modulation of hepatitis C virus 1a replication by PKR is dependent on NF-kB mediated interferon beta response in Huh7.5.1 cells |
| Q38620980 | Use of functional genomics to understand replication deficient poxvirus-host interactions |
| Q24609947 | Viral double-stranded RNAs from vaccinia virus early or intermediate gene transcripts possess PKR activating function, resulting in NF-kappaB activation, when the K1 protein is absent or mutated |
Search more.